Key result
Early-stage breast cancer in older women is linked to significant cardiovascular mortality risk.
Cardiovascular death is a significant competing risk in older women with early-stage breast cancer, highlighting the need for cardiovascular preventive therapy.
May warrant CV monitoring in older early-stage breast cancer survivors; leaves open whether preventive therapies improve outcomes.
Cardiovascular death is an important competing risk for older women with early-stage breast cancer. This finding mandates adequate attention to cardiovascular preventive therapy after diagnosis of breast cancer.
No takes yet. Share an insight, caveat, or question.
Abdel‐Qadir et al. (2016) studied this question. Older women with early-stage breast cancer face significant cardiovascular mortality risk, highlighting the need for effective cardiovascular preventive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: